Pharmaniaga misrepresented Sinovac-Pfizer combo, says MoH
Pharmaniaga Bhd’s claim of lower heterologous boosting effectiveness for Sinovac primary vaccination recipients against Omicron was refuted by the Institute ...
Read morePharmaniaga Bhd’s claim of lower heterologous boosting effectiveness for Sinovac primary vaccination recipients against Omicron was refuted by the Institute ...
Read moreDue to the delay in Pharmaniaga Berhad’s delivery of the Covid-19 vaccine in April, May and June, the government paid a ...
Read moreDUOPHARMA Biotech Berhad has further strengthened Malaysia’s Covid-19 vaccination efforts by distributing the Sinopharm Covid-19 vaccine. The company had earlier entered ...
Read moreThe government should ensure access of halal certified medication to Muslim patients to ease their minds BY ALISA AMINUDIN The ...
Read moreWe need to ensure a high level of vaccination readiness BY AMEEN KAMAL Assuming a linear projection rate based on total ...
Read moreThe inequitable distribution of Covid-19 vaccines illustrates the limits of a system where power plays a part BY DR WAEL ...
Read moreIn Malaysia, the vaccine has been concluded as harus (permissible) and wajib (mandatory) BY KHIRTINI K KUMARAN [caption id="attachment_3415" align="alignright" ...
Read moreFair distribution of the Covid-19 vaccine requires local and global solidarity to ensure no country is left out BY AMEEN ...
Read moreA successful vaccination programme is our exit strategy for this pandemic BY KHIRTINI K KUMARAN A virtual forum on ‘Covid Control and ...
Read moreThe efficacy of the Covid-19 vaccines is generally great, with some vaccines cited beyond 95 per cent BY PROF ...
Read moreRevon Media Sdn Bhd
A member of Revongen Corporation
Headquarters
Revongen Corporation Center,
Level 17, Top Glove Tower, No.16,
Persiaran Setia Dagang,Setia Alam,
Seksyen U13, 40170 Shah Alam,
Selangor Darul Ehsan, Malaysia.
Tel: +603 3359 1166
Fax: +6 03 3358 0303
Copyright © 2021 Revon Media Sdn Bhd. A publication of Revon Media Sdn Bhd. About Us | Contact Us | Privacy Policy | Terms of use